Kyle White
Family · Sierra Vista, AZNPI 1497293328
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,277 of the $15,030 with a category attached, or 68.4%. 36 manufacturers reported payments, led by Abbott at 30.3% of the total. Reporting peaked in 2024 at $4,456 and has fallen 67.8% since, to $1,435 in 2025. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $38.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$4K
- Pacira Pharmaceuticals Incorporated$1K
- AbbVie$1K
- Collegium Pharmaceutical, Inc.$772
- Biodelivery Sciences International, Inc.$673
- plus $3K from 30 others
What the payments were for
- Speaking & faculty fees$6004%
- Travel & lodging$4,05427%
- Food & beverage$10,27768%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 92 | $4,560 |
| Medtronic | 94 | $4,071 |
| Pacira Pharmaceuticals Incorporated | 5 | $1,176 |
| AbbVie(2 entities) | 33 | $1,057 |
| Collegium Pharmaceutical, Inc. | 50 | $772 |
| Biodelivery Sciences International, Inc. | 6 | $673 |
| Boston Scientific | 18 | $472 |
| Amgen | 11 | $253 |
| Globus Medical | 5 | $239 |
| SPR Therapeutics, Inc | 2 | $179 |
| Pfizer | 10 | $171 |
| Nalu Medical, Inc. | 7 | $155 |
| Lundbeck LLC | 7 | $154 |
| Vertex | 2 | $115 |
| Saluda Medical Americas, Inc. | 3 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $90 |
| Teva Pharmaceuticals USA, Inc. | 5 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $79 |
| Nevro Corp. | 2 | $77 |
| Lilly USA, LLC | 5 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| Biotronik NRO, Inc. | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $41 |
| Pacira Therapeutics, Inc. | 1 | $41 |
| Merz Pharmaceuticals, LLC | 2 | $40 |
| Microtransponder, Inc. | 1 | $38 |
| Eisai Inc. | 2 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Piramal Critical Care | 1 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Tonix Medicines, Inc. | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,112
- Iovera$1,059
- SYNCHROMEDII$624
- BELBUCA$600
- ETERNA$522
- INTELLIS$492
- Axium$294
- UBRELVY$250
- VANTA ADAPTIVESTIM$200
- INTELLIS ADAPTIVESTIM$176
- Senza$170
- Superion Indirect Decompression System$142
- SPRINT PNS System$141
How this compares
$15,030 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 35 | $21,413 |
| BelbucaBuprenorphine Hcl | 24 | $16,198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 644 | $15,336 |
| Pregabalin | 357 | $13,749 |
| Gabapentin | 581 | $9,196 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 319 | $8,843 |
| Buprenorphine | 53 | $8,318 |
| Oxycodone Hcl | 371 | $7,884 |
| SymproicNaldemedine Tosylate | 11 | $5,153 |
| MovantikNaloxegol Oxalate | 12 | $5,093 |
| Duloxetine Hcl | 189 | $4,979 |
| ButransBuprenorphine | 11 | $3,756 |
| Morphine Sulfate ErMorphine Sulfate | 107 | $2,260 |
| Lidocaine | 17 | $2,122 |
| Baclofen | 99 | $2,115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $772 | $37,61159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Sierra Vista
- Sharon MagalonaMesa$441K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Celeste FineGilbert$82K
- Mia ChorneyChandler$79K
- Jennifer PrinceScottsdale$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.